FDA Approved: DIHYDROERGOTAMINE MESYLATE NASAL — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla's dihydroergotamine mesylate nasal product via a supplemental application, enabling its marketed use in the United States for acute migraine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine Mesylate Nasal (dihydroergotamine mesylate nasal spray)

Snippet

SUPPL AP for DIHYDROERGOTAMINE MESYLATE NASAL (DIHYDROERGOTAMINE MESYLATE NASAL)